Hone Health raises $228 million with backing from Jay-Z's MarcyPen and Gwyneth Paltrow

Hone Health raises $228 million with backing from Jay-Z's MarcyPen and Gwyneth Paltrow

Online clinic Hone Health secures $228 million in new financing

Hone Health, an online clinic that started by treating men with low testosterone, has announced $228 million in new financing. The money includes a $28 million equity round led by MarcyPen Capital Partners, the investment firm cofounded by Shawn “Jay-Z” Carter, Jay Brown, and Robbie and D’Rita Robinson.

The company also disclosed for the first time that MarcyPen led its earlier Series A round. Hone said the firm “has historically maintained a low public profile, allowing their portfolio companies to remain at the center of their own stories.”

Key numbers and backers

  • $228 million total in new financing, announced Wednesday.
  • $28 million of that is equity, raised as an extension of the Series A rather than a Series B.
  • $200 million comes from General Catalyst’s Customer Value Fund.
  • Total equity funding for Hone now stands at $65 million.
  • Hone passed $100 million in recurring revenue last year, according to cofounder Saad Alam.
  • About 200,000 patients have been treated since launch. In January 2025, the company reported 55,000 patients treated.

The celebrity investors involved

Other equity backers include Kinship Ventures, the firm Gwyneth Paltrow cofounded with Moj Mahdara, along with Pentland Ventures, Hanwha, Gannet Capital, and Humbition. Individual investors include the Jonas Brothers (Nick, Joe, and Kevin Jonas), singer Kelly Rowland, actor Marcello Hernández, hospitality entrepreneurs David Grutman, Jason Strauss, and Noah Tepperberg, and Quentin Dolan, whose father controls the New York Knicks.

Paltrow said she is also a Hone patient. “I did all my labs and blood work and everything. I started a protocol that was incredibly helpful,” she said, adding that testing found gut bacteria issues and unbalanced hormones. Mahdara said in the announcement that “the next great health company will be built on data.”

Jay Brown of MarcyPen called Alam and his team “proven business builders.” Charlie Hanna, a managing director at the firm, said MarcyPen has “been incredibly impressed by their ambition and execution.”

Alam said he pitched Dolan when Hone launched six years ago and was told it was too early. He said Dolan came up through the Knicks’ athletic side, working with trainers on the kind of measurements Hone does with patients.

How the $228 million breaks down

Only $28 million is traditional equity. The remaining $200 million comes from General Catalyst’s Customer Value Fund, which pays for a large share of a company’s sales and marketing and is repaid from the revenue new customers bring in.

Alam said he can call General Catalyst each month and ask for $10 million, spend it on acquiring patients, then repay a portion of the profit from those patients plus interest. He said the deal has no recourse and no covenants restricting Hone from raising other money, unlike a bank loan, and that the interest rate is small. General Catalyst offers the arrangement only to companies whose patients stay at a steady rate, according to Alam.

He said most of the $28 million will go toward AI tools that let one physician handle problems that would normally send a patient to several specialists.

Hone Black, a concierge tier, and a bigger plan

Hone is also launching Hone Black, a concierge membership that has quietly run for a small group of high-profile patients. It pairs testing of more than 1,600 health markers with a dedicated team of physicians. Alam said the program started when people asked how he kept up his energy at 44, and he sees it as a test bed for treatments that may later reach Hone’s main product.

Hone is the first business under a parent company called Time Therapeutics. Alam’s plan has three stages: build a large online clinic, use its patient base to run clinical trials remotely, then partner with drugmakers and research centers to bring drugs to market faster in exchange for equity.

Why the company exists

Alam said that at 35, he told his doctor he was depressed and gaining weight despite eating well, sleeping well, and being a lifelong athlete. He said the doctor offered Viagra and an antidepressant, which he rejected. After months of visits to endocrinologists, urologists, and cardiologists, doctors found he had low testosterone. That experience led him to cofound Hone Health in 2020.

Sources

Newisty Editorial Team
Written by

Newisty Editorial Team

Technology · Crypto · Digital Economy
View all posts

Newisty Editorial Team covers technology, cryptocurrency, digital products, online platforms, developer tools and the wider digital economy. Our content is researched from official sources, company announcements, public documentation, market data and other primary or reputable sources. Articles are reviewed and edited before publication for clarity, accuracy and useful context.

Comments (0)

Leave a comment
Your comment will appear publicly after submission.
No comments yet. Be the first to comment!